Genetics and Gene Panel Testing Working Group

Date: Friday 18 October 2019
Time: 08:00 – 10:00
Chairs: Gabriel Capella (Spain), Elke Holinski-Feder (Germany)

Time Session
08:00 – 08:15 What if we would use a diagnostic multi-cancer gene panel for opportunistic screening? A study in 2,090 Dutch familial cancer patients – Rolf Sijmons (The Netherlands)
08:15 – 08:30 Prevalence of pathogenic variants of FAN1 among more than 5000 consecutive patients referred to one genetic clinic for suspected hereditary predisposition to colorectal, breast/ovarian or other cancers – Marine Le Mentec (France)
08:30 – 08:45 SigProfilerWeb: a user-friendly web application for accurately determining the activities of mutational signatures – Marcos Diaz-Gay (Spain)
08:45 – 09:00 Long term follow-up and advances in genetic technologies result in improved management of families with inherited colorectal cancers – D. Gareth Evans (UK)
09:00 – 09:15 The Clinical Utility of Tumour Mutational Signatures for Identifying Hereditary Colorectal Cancer and Polyposis syndromes – Daniel Buchanan (UK)
09:15 – 09:30 High Likelihood of actionable pathogenic variants in breastcancer genes in women with very early onset breast cancer – D. Gareth Evans (UK)
09:30 – 09:45 Multiple Genetic Tumor Syndromes (MGTS):when to suspect them? – Emanuela Lucci-Cordisco (Italy)
09:45 – 10:00 National recommendations of the French Genetics Cancer Group – Uniancer on the modalities of multi-gene panel analysis in hereditary predispositions to tumours of the digestive tract – Chrystelle Colas (France)